Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
2018 · BMC Cancer · 19 citations
https://doi.org/10.1186/s12885-018-4588-y
Y
Yuko Murakami
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
540
Citations
11
h-index
11
i10-index
Yuko Murakami is an academic researcher. The author has contributed to research in topics: Hepatitis C virus research & Ethics and Social Impacts of AI & Genomics, phytochemicals, and oxidative stress. The author has an h-index of 11, co-authored 52 publications.
ORCID: 0000-0003-1428-2785Papers by this author
worksmicroRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line
2016 · BMC Cancer · 4 citations
https://doi.org/10.1186/s12885-016-2762-7
Additional file 3: of Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.6679589
Additional file 1: of Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.6679553
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat